Literature DB >> 1335556

The modulation of dopaminergic transmission in the striatum by MK-801 is independent of presynaptic mechanisms.

O Gandolfi1, R Rimondini, R Dall'Olio.   

Abstract

This paper reports biochemical and behavioural experiments, planned to obtain a deeper knowledge on the mechanisms of the facilitating action of dopaminergic transmission, induced by the NMDA-sensitive glutamate receptor antagonist, dizocilpine (MK-801). Single or repeated administrations of MK-801 (0.25 mg/kg, i.p., daily for 21 consecutive days) failed to change levels of either dopamine (DA) and dihydroxyphenylacetic acid (DOPAC) in the striatum of the rat or the haloperidol-induced (0.125 mg/kg, i.p.) accumulation of DOPAC. Consistently, the NMDA antagonist, given at a dose which did not affect the spontaneous motility of the animal (0.125 mg/kg, i.p.), failed to potentiate the behavioural stimulatory effect, induced by the dopaminomimetic agents, methamphetamine or nomifensine. All these results, taken together, exclude a facilitating action of MK-801 on dopaminergic neurotransmission. The possibility that the stimulatory effect of MK-801 on dopaminergic neurones is indirect and independent of presynaptic mechanisms is discussed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1335556     DOI: 10.1016/0028-3908(92)90006-b

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  3 in total

1.  Effect of NMDA receptor antagonists on D1, D2 and D1/D2 mediated behaviors in intact rats.

Authors:  R Dall'Olio; R Rimondini; O Gandolfi
Journal:  Psychopharmacology (Berl)       Date:  1996-01       Impact factor: 4.530

2.  The competitive NMDA antagonists CGP 43487 and APV potentiate dopaminergic function.

Authors:  R Dall'Olio; R Rimondini; O Gandolfi
Journal:  Psychopharmacology (Berl)       Date:  1995-04       Impact factor: 4.530

3.  Effect of glutamate receptor antagonists on suckling-induced prolactin release in rats.

Authors:  Dóra Zelena; Gábor B Makara; György M Nagy
Journal:  Endocrine       Date:  2003-07       Impact factor: 3.633

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.